| Literature DB >> 32930582 |
Soumen Chakraborty1,2, Susruta Majumdar1,2.
Abstract
Pain remains a very pervasive problem throughout medicine. Classical pain management is achieved through the use of opiates belonging to the mu opioid receptor (MOR) class, which have significant side effects that hinder their utility. Pharmacologists have been trying to develop opioids devoid of side effects since the isolation of morphine from papaver somniferum, more commonly known as opium by Sertürner in 1804. The natural products salvinorin A, mitragynine, and collybolide represent three nonmorphinan natural product-based targets, which are potent selective agonists of opioid receptors, and emerging next-generation analgesics. In this work, we review the phytochemistry and medicinal chemistry efforts on these templates and their effects on affinity, selectivity, analgesic actions, and a myriad of other opioid-receptor-related behavioral effects.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32930582 PMCID: PMC7982354 DOI: 10.1021/acs.biochem.0c00629
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162